Rosetta Capital
Investor profile
Investment firm
Rosetta Capital has backed 2 European tech companies across 2 funding rounds between 2014 and 2025, joining rounds totalling €60M. Most active in Healthtech. Data as of Nov 2026.
Deals
2
distinct rounds
Companies
2
backed
Active span
2014–2025
12 yrs
Total round €
€60M
sum of rounds joined
Deals by year
distinct rounds / yearRosetta Capital — deals by year — interactive chart.
Data table
| Rosetta Capital — deals by year | |
|---|---|
| 2014 | 1 |
| 2025 | 1 |
Top sectors
by dealsRosetta Capital — top sectors — interactive chart.
Data table
| Rosetta Capital — top sectors | |
|---|---|
| Healthtech | 2 |
Stages
by dealsRosetta Capital — stages — interactive chart.
Data table
| Rosetta Capital — stages | |
|---|---|
| Other | 1 |
| Series D+ | 1 |
Countries
by dealsRosetta Capital — countries — interactive chart.
Data table
| Rosetta Capital — countries | |
|---|---|
| Switzerland | 1 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| NovImmune | Switzerland | 1 | €49M |
| MISSION Therapeutics | UK | 1 | €11M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| NovImmune | Series D+ | €49M | 2014-02 |
| MISSION Therapeutics | Other | €11M | 2025-10 |